This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CHFS vs. PTHL, QTI, IRIX, NRXS, BSGM, STRR, MOVE, TIVC, NUWE, and NDRAShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Pheton Holdings Ltd Class A Ordinary Shares (PTHL), QT Imaging (QTI), IRIDEX (IRIX), NeurAxis (NRXS), BioSig Technologies (BSGM), Star Equity (STRR), Movano (MOVE), Tivic Health Systems (TIVC), Nuwellis (NUWE), and ENDRA Life Sciences (NDRA). Nuwellis vs. Pheton Holdings Ltd Class A Ordinary Shares QT Imaging IRIDEX NeurAxis BioSig Technologies Star Equity Movano Tivic Health Systems Nuwellis ENDRA Life Sciences Nuwellis (NASDAQ:CHFS) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment. Do insiders and institutionals have more ownership in CHFS or PTHL? 65.1% of Nuwellis shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer CHFS or PTHL? In the previous week, Pheton Holdings Ltd Class A Ordinary Shares had 1 more articles in the media than Nuwellis. MarketBeat recorded 1 mentions for Pheton Holdings Ltd Class A Ordinary Shares and 0 mentions for Nuwellis. Pheton Holdings Ltd Class A Ordinary Shares' average media sentiment score of 1.91 beat Nuwellis' score of 0.00 indicating that Pheton Holdings Ltd Class A Ordinary Shares is being referred to more favorably in the news media. Company Overall Sentiment Nuwellis Neutral Pheton Holdings Ltd Class A Ordinary Shares Very Positive Is CHFS or PTHL more profitable? Pheton Holdings Ltd Class A Ordinary Shares has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. Pheton Holdings Ltd Class A Ordinary Shares' return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-254.26% -173.61% -131.01% Pheton Holdings Ltd Class A Ordinary Shares N/A N/A N/A Which has preferable valuation and earnings, CHFS or PTHL? Pheton Holdings Ltd Class A Ordinary Shares has lower revenue, but higher earnings than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$5.51M1.08-$18.11M-$279.280.00Pheton Holdings Ltd Class A Ordinary Shares$448.20K55.22N/AN/AN/A Does the MarketBeat Community prefer CHFS or PTHL? Nuwellis received 324 more outperform votes than Pheton Holdings Ltd Class A Ordinary Shares when rated by MarketBeat users. CompanyUnderperformOutperformNuwellisOutperform Votes32469.53% Underperform Votes14230.47% Pheton Holdings Ltd Class A Ordinary SharesN/AN/A SummaryPheton Holdings Ltd Class A Ordinary Shares beats Nuwellis on 6 of the 10 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.98M$3.20B$5.50B$7.98BDividend YieldN/A1.80%5.11%4.23%P/E Ratio-0.0215.5822.6318.59Price / Sales1.0854.01398.09103.52Price / CashN/A44.0938.1834.62Price / Book0.083.566.724.27Net Income-$18.11M$94.03M$3.22B$248.18M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$0.99-1.0%N/A+547.7%$5.98M$5.51M-0.0266PTHLPheton Holdings Ltd Class A Ordinary SharesN/A$2.91+6.8%N/AN/A$19.12M$448,196.000.0011Positive NewsGap UpQTIQT ImagingN/A$0.70+6.4%N/A-5.1%$18.99M$4.00M0.00N/AUpcoming EarningsIRIXIRIDEX2.1388 of 5 stars$1.02-1.0%$2.00+96.1%-58.2%$17.13M$48.67M-1.52120News CoverageNRXSNeurAxisN/A$1.81+13.1%N/A-26.6%$13.06M$2.69M-0.9819High Trading VolumeBSGMBioSig Technologies2.2654 of 5 stars$0.54+0.3%$2.50+366.4%-38.0%$9.24M$39,000.000.0050Positive NewsSTRRStar Equity2.1206 of 5 stars$1.80-1.6%N/A-52.5%$5.79M$53.36M-0.70460Short Interest ↓Positive NewsMOVEMovano2.1764 of 5 stars$0.82-12.1%$30.00+3,549.6%-87.3%$5.78M$1.01M-0.1630Short Interest ↑TIVCTivic Health Systems0.1841 of 5 stars$8.53+143.6%N/A-75.3%$5.34M$780,000.000.0010Short Interest ↑Gap DownHigh Trading VolumeNUWENuwellis3.0511 of 5 stars$0.91+1.4%$17.00+1,778.5%-81.7%$3.96M$8.74M-0.0170Short Interest ↓Gap DownNDRAENDRA Life Sciences2.262 of 5 stars$3.32-1.2%$50.00+1,406.0%-100.0%$1.87MN/A0.0020Short Interest ↑Gap Down Related Companies and Tools Related Companies PTHL Alternatives QTI Alternatives IRIX Alternatives NRXS Alternatives BSGM Alternatives STRR Alternatives MOVE Alternatives TIVC Alternatives NUWE Alternatives NDRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHFS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CHFS Stock Free CHFS Stock Alerts